The antileukemic efficacy of CAR-NK cells is shaped by clonal expression of inhibitory KIRs and patient-encoded KIR ligands

Molecular Therapy Advances · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles